866-997-4948(US-Canada Toll Free)

Metastatic Ovarian Cancer Global Clinical Trials Review, H2, 2016

Published By :

GlobalData

Published Date : Jul 2016

Category :

Ovarian Cancer

No. of Pages : 104 Pages

Metastatic Ovarian Cancer Global Clinical Trials Review, H2, 2016

Summary

GlobalData's clinical trial report, Metastatic Ovarian Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Metastatic Ovarian Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Metastatic Ovarian Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Metastatic Ovarian Cancer to Oncology Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Metastatic Ovarian Cancer to Oncology Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials in E7 Countries by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Metastatic Ovarian Cancer Therapeutics Clinical Trials 26
Prominent Drugs 28
Latest Clinical Trials News on Metastatic Ovarian Cancer 29
Jul 28, 2016: Use Of Parsortix In GANNET53 Drug Trial In Ovarian Cancer 29
Clinical Trial Profile Snapshots 30
Appendix 101
Abbreviations 101
Definitions 101
Research Methodology 102
Secondary Research 102
About GlobalData 103
Contact Us 103
Disclaimer 103
Source 104

List of Tables
Metastatic Ovarian Cancer Therapeutics, Global, Clinical Trials by Region, 2016* 6
Metastatic Ovarian Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Metastatic Ovarian Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Metastatic Ovarian Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
Metastatic Ovarian Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
Metastatic Ovarian Cancer Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
Metastatic Ovarian Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12
Proportion of Metastatic Ovarian Cancer to Oncology Clinical Trials, G7 Countries (%), 2016* 13
Metastatic Ovarian Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14
Metastatic Ovarian Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15
Proportion of Metastatic Ovarian Cancer to Oncology Clinical Trials, E7 Countries (%), 2016* 16
Metastatic Ovarian Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17
Metastatic Ovarian Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18
Metastatic Ovarian Cancer Therapeutics, Global, Clinical Trials by Phase, 2016* 19
Metastatic Ovarian Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 20
Metastatic Ovarian Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21
Metastatic Ovarian Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22
Metastatic Ovarian Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23
Metastatic Ovarian Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 24
Metastatic Ovarian Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25
Metastatic Ovarian Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
Metastatic Ovarian Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28

List of Figures
Metastatic Ovarian Cancer Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Metastatic Ovarian Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Metastatic Ovarian Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Metastatic Ovarian Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
Metastatic Ovarian Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
Metastatic Ovarian Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
Proportion of Metastatic Ovarian Cancer to Oncology Clinical Trials, G7 Countries (%), 2016* 13
Metastatic Ovarian Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14
Metastatic Ovarian Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15
Proportion of Metastatic Ovarian Cancer to Oncology Clinical Trials, E7 Countries (%), 2016* 16
Metastatic Ovarian Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17
Metastatic Ovarian Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18
Metastatic Ovarian Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2016* 19
Metastatic Ovarian Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 20
Metastatic Ovarian Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21
Metastatic Ovarian Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22
Metastatic Ovarian Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23
Metastatic Ovarian Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 24
Metastatic Ovarian Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25
Metastatic Ovarian Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 26
Metastatic Ovarian Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28
GlobalData Methodology 102

List of Table

NA

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *